OMNIAB INC Share Price Today: Live Updates & Key Insights

OMNIAB INC share price today is $1.7486, up -4.89%. The stock opened at $1.82 against the previous close of $1.84, with an intraday high of $1.83 and low of $1.75.

OMNIAB INC Share Price Chart

OMNIAB INC

us-stock
To Invest in {{usstockname}}
us-stock

OMNIAB INC Share Price Performance

$1.7486 -0.0489(-4.89%) OABI at 23 Mar 2026 02:33 PM Biotechnology
Lowest Today 1.75
Highest Today 1.83
Today’s Open 1.82
Prev. Close 1.84
52 Week High 2.57
52 Week Low 1.22
Day’s Range: Low 1.75 High 1.83
52-Week Range: Low 1.22 High 2.57
1 day return -
1 Week return -4.89
1 month return +1.15
3 month return -14.42
6 month return +3.24
1 year return -31.23
3 year return -47.28
5 year return -82.23
10 year return -

OMNIAB INC Institutional Holdings

Whitefort Capital Management, LP. 9.82

BlackRock Inc 4.81

Vanguard Group Inc 3.89

Cadian Capital Management LP 3.06

Geode Capital Management, LLC 1.88

Vanguard Total Stock Mkt Idx Inv 1.78

iShares Russell 2000 ETF 1.72

Private Management Group Inc 1.67

Rice Hall James & Associates, LLC 1.66

Dimensional Fund Advisors, Inc. 1.49

State Street Corp 1.45

JPMorgan Chase & Co 1.05

Vanguard Institutional Extnd Mkt Idx Tr 0.91

Fidelity Small Cap Index 0.72

Towerview LLC 0.69

Charles Schwab Investment Management Inc 0.67

Nuveen, LLC 0.60

Morgan Stanley - Brokerage Accounts 0.57

iShares Biotechnology ETF 0.57

Northern Trust Corp 0.57

iShares Russell 2000 Value ETF 0.53

ADAR1 Capital Management LLC 0.49

Stonepine Capital Management Llc 0.48

CREF Total Global Stock Account R3 0.48

Millennium Management LLC 0.47

ISTHMUS Partners LLC 0.46

Fidelity Extended Market Index 0.43

Isthmus Small Cap Core Equity 0.41

The Goldman Sachs Group Inc 0.41

Schwab US Small-Cap ETF™ 0.39

State St Russell Sm/Mid Cp® Indx SL Cl I 0.37

Vanguard Russell 2000 ETF 0.35

DFA US Micro Cap I 0.25

DFA US Small Cap I 0.23

State St Russell Sm Cap® Indx SL Cl I 0.22

iShares Micro-Cap ETF 0.19

Vanguard Health Care ETF 0.18

Schwab Small Cap Index 0.18

NT R2000 Index Fund - NL 0.17

Blackrock Extended Mkt Fund CF 0.17

OMNIAB INC Market Status

Strong Buy: 6

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

OMNIAB INC Fundamentals

Market Cap 253.37 M

PB Ratio 0.9977

PE Ratio 0.0

Enterprise Value 219.68 M

Total Assets 300.91 M

Volume 953649

OMNIAB INC Company Financials

Annual Revenue FY23:64687000 64.7M, FY22:59077000 59.1M, FY21:34748000 34.7M, FY20:23268000 23.3M, FY19:18318000 18.3M

Annual Profit FY23:null 0.0M, FY22:59077000 59.1M, FY21:34748000 34.7M, FY20:23268000 23.3M, FY19:18318000 18.3M

Annual Net worth FY23:-29746000 -29.7M, FY22:-22334000 -22.3M, FY21:-27042000 -27.0M, FY20:-17557000 -17.6M, FY19:-13589000 -13.6M

Quarterly Revenue Q3/2025:2239000 2.2M, Q2/2025:3897000 3.9M, Q1/2025:4154000 4.2M, Q3/2024:4172000 4.2M, Q2/2024:7614000 7.6M

Quarterly Profit Q3/2025:-2445000 -2.4M, Q2/2025:3635000 3.6M, Q1/2025:4154000 4.2M, Q3/2024:4172000 4.2M, Q2/2024:1513000 1.5M

Quarterly Net worth Q3/2025:-16524999 -16.5M, Q2/2025:-15875000 -15.9M, Q1/2025:-18200000 -18.2M, Q3/2024:-16373000 -16.4M, Q2/2024:-13631000 -13.6M

About OMNIAB INC & investment objective

Company Information OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company offers animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. It has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

Organisation Biotechnology

Employees 89

Industry Biotechnology

CEO Mr. Matthew W. Foehr

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

OMNIAB INC FAQs

What is the share price of OMNIAB INC today?

The current share price of OMNIAB INC is $1.7486.

Can I buy OMNIAB INC shares in India?

Yes, Indian investors can buy OMNIAB INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy OMNIAB INC shares in India?

You can easily invest in OMNIAB INC shares from India by:

Can I buy fractional shares of OMNIAB INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of OMNIAB INC?

OMNIAB INC has a market cap of $253.37 M.

In which sector does OMNIAB INC belong?

OMNIAB INC operates in the Biotechnology sector.

What documents are required to invest in OMNIAB INC stocks?

To invest, you typically need:

What is the PE and PB ratio of OMNIAB INC?

The PE ratio of OMNIAB INC is N/A and the PB ratio is 1.00.